Guide to Drug Financing Mechanisms
(1998; 64 pages) [French] [Spanish]
Table of Contents
View the documentForeword
View the documentAcknowledgements
Close this folderIntroduction
View the documentObjectives
View the documentAudience
View the documentConcepts
View the documentPlan of this book
Open this folder and view contentsChapter 1. Selection
Open this folder and view contentsChapter 2. Procurement
Open this folder and view contentsChapter 3. Distribution
Open this folder and view contentsChapter 4. Prescribing
Open this folder and view contentsSummary: contributions and limitations of the economic approach
View the documentReferences
View the documentSelected WHO publications of related interest
View the documentBack cover
 

Plan of this book

The topics discussed here are those to which economic methods are most relevant. Quantification has been studied in depth elsewhere (4). Utilization is an area of research that is now expanding fast (5). It is discussed here only with regard to the economic aspects of prescribing. The main aspects of pharmaceutical supply are therefore examined as follows: selection (Chapter 1), procurement (Chapter 2), distribution (Chapter 3), and prescribing (Chapter 4).

The links between the pharmaceutical supply system, the financing system and the information system are studied with regard to each aspect. Each is examined under three headings: What are the objectives? What processes allow these objectives to be attained? What structures and organizational arrangements are needed to carry out these processes and attain these objectives?

 

to previous section to next section
 

Last updated: May 3, 2013